SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-044302
Filing Date
2021-08-13
Accepted
2021-08-13 16:06:13
Documents
92
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q fmtx-10q_20210630.htm   iXBRL 10-Q 3753081
2 EX-31.1 fmtx-ex311_6.htm EX-31.1 15575
3 EX-31.2 fmtx-ex312_7.htm EX-31.2 15699
4 EX-32.1 fmtx-ex321_10.htm EX-32.1 8032
  Complete submission text file 0001564590-21-044302.txt   11795997

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA fmtx-20210630.xsd EX-101.SCH 75442
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fmtx-20210630_cal.xml EX-101.CAL 58534
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fmtx-20210630_def.xml EX-101.DEF 233743
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE fmtx-20210630_lab.xml EX-101.LAB 511185
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fmtx-20210630_pre.xml EX-101.PRE 411546
10 EXTRACTED XBRL INSTANCE DOCUMENT fmtx-10q_20210630_htm.xml XML 2241984
Mailing Address 500 ARSENAL STREET SUITE 100 WATERTOWN MA 02472
Business Address 500 ARSENAL STREET SUITE 100 WATERTOWN MA 02472 617-679-1970
Forma Therapeutics Holdings, Inc. (Filer) CIK: 0001538927 (see all company filings)

IRS No.: 371657129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39333 | Film No.: 211172094
SIC: 2836 Biological Products, (No Diagnostic Substances)